The FTSE 100 Index has risen 2.1 points, or less than 0.1%, to 5597.50 in the first hour of trading after the Christmas break.
UK stocks including AstraZeneca have advanced after the drugmaker announced plans to develop a treatment for Alzheimer's and schizophrenia. BP has declined on falling crude-oil futures. AstraZeneca, the UK's second-largest drugmaker, has climbed 36p, or 1.3%, to 283.1p. The company says it has agreed to pay Turgescent as much as $300m over four years to help develop TC-1734, an experimental treatment. BP, Europe's biggest oil company, has fallen 10p, or 1.6%, to 611.5p while Royal Dutch Shell, the region's second- largest energy producer, has also lost 20p, or 1.1%, to 1,754p. Crude o...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
